Avita Medical, Inc. (RCEL) Financials

RCEL Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 63.6 million 42.3 million
2023-12-31 76.1 million 42.6 million
2023-09-30 81.0 million 18.0 million
2023-06-30 86.0 million 17.6 million

RCEL Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -14.4 million 1.7 million
2023-12-31 -7.6 million 1.5 million
2023-09-30 -9.5 million 2.4 million
2023-06-30 -9.4 million 1.1 million

RCEL Net Income

No data available :(

RCEL Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 - - 2.2 million
2023-12-31 - - 1.8 million
2023-09-30 60.1 million - 1.8 million
2023-06-30 65.8 million - 694610

RCEL Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 16.8 million
2023-12-31 17.5 million
2023-09-30 16.3 million
2023-06-30 16.7 million

RCEL Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 803522 3.4 million 14.1 million -
2023-12-31 224829 4.6 million 12.2 million -
2023-09-30 501966 4.4 million 6.0 million 10.5 million
2023-06-30 297825 5.1 million 5.9 million 10.0 million

RCEL Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 7.3 million 988397
2023-12-31 9.7 million 1.2 million
2023-09-30 13.6 million 2.1 million
2023-06-30 11.7 million 2.2 million

RCEL

Price: $8.27

52 week price:
7.51
21.70

Earnings Per Share: -1.40 USD

P/E Ratio: -13.04

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Volume: 159000

Market Capitalization: 213.4 million

Links: